NUVATION BIO INC (NUVB)

US67080N1019 - Common Stock

3.32  -0.09 (-2.64%)

After market: 3.32 0 (0%)

Buy % Consensus

87

ChartMill assigns a Buy % Consensus number of 87% to NUVB. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 6.02. This target is 81.27% above the current price.
NUVB was analyzed by 11 analysts. The buy percentage consensus is at 87. So analysts seem to be very confident about NUVB.
In the previous month the buy percentage consensus was at a similar level.
NUVB was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 3.324.555.106.0210.50 - 36.90% 53.61% 81.27% 216.27%
Up and Down Grades
Date Firm Action Rating
2024-05-15 Wedbush Reiterate Outperform -> Outperform
2024-04-17 RBC Capital Maintains Outperform -> Outperform
2024-03-28 HC Wainwright & Co. Maintains Buy -> Buy
2024-03-27 JP Morgan Maintains Neutral -> Neutral
2024-03-27 Jefferies Upgrade Hold -> Buy
2024-03-26 BTIG Upgrade Neutral -> Buy
2024-03-07 HC Wainwright & Co. Maintains Buy -> Buy
2024-03-01 Wedbush Reiterate Outperform -> Outperform
2023-11-22 HC Wainwright & Co. Reiterate Buy -> Buy
2023-08-21 HC Wainwright & Co. Reiterate Buy -> Buy
2023-05-05 RBC Capital Maintains Outperform
2023-03-24 HC Wainwright & Co. Reiterate Buy
2023-03-16 RBC Capital Reiterate Outperform
2023-03-16 Wedbush Reiterate Outperform
2023-01-06 Jefferies Downgrade Buy -> Hold
2022-08-22 HC Wainwright & Co. Maintains Buy
2022-08-02 BMO Capital Downgrade Outperform -> Market Perform
2022-08-02 BTIG Downgrade Buy -> Neutral
2022-05-11 RBC Capital Maintains Outperform
2022-05-04 HC Wainwright & Co. Initiate Buy
2021-04-06 RBC Capital Initiate Outperform
2021-03-08 BMO Capital Initiate Outperform
2021-03-08 BTIG Initiate Buy
2021-03-08 Cowen & Co. Initiate Outperform
2021-03-08 Wedbush Initiate Outperform
2021-03-08 Jefferies Initiate Buy